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Supplementary Figure 1 
Freebayes workflow 
Freebayes workflow can be used for small variant discovery and genotyping and splits into tasks by chromosome, where each task can 
run in parallel (not all tasks are visible in figure to save space). Workflow is started and ended by standard start_analysis_run and 




Supplementary Figure 2 
Freebayes task durations 
Boxplot of freebayes task durations during the SNV genotyping stage across 5668 samples. Durations are highly correlated with 
chromosome length (Pearson’s r=0.92). n=5668 biologically independent samples Boxplot center line corresponds to the median, lower 





Supplementary Figure 3 
Delly workflow durations 
(a) Distribution of Delly workflow durations for genotyping of 244,889 germline deletions across 5668 PCAWG  samples. (b) Distribution 
of Delly workflow durations for genotyping of 217,433 germline duplications across 5668 PCAWG samples.  n=5668 biologically 




Supplementary Figure 4 
Analysis Tracker UML diagram 
The Analysis Tracker consists of four entities that are necessary for keeping track of the state of scientific analyses run in Butler. The 
Workflow object keeps a registry of known workflows and their attributes. The Analysis object keeps track of analyses that are being 
performed. An Analysis Run represents an instance of running a particular workflow under a particular analysis on a particular sample. 




Supplementary Figure 5 
Analysis Run state transitions 
Each Analysis Run keeps track of its state and has a set of rules governing allowable state transitions. A Run is created in the Ready 
state from which it may be scheduled for execution. Once the corresponding workflow task is picked up for execution it is transitioned to 
In-Progress. Upon successful completion it is marked Completed. At any point a failure may put this run in an Error state from which it 
 
 




Supplementary Figure 6 
Hierarchical tri-level configuration 
Configuration can be applied at three levels of granularity within Butler - Workflow, Analysis, and Analysis Run. Each higher level 
configuration may override and augment the configurations supplied at lower levels. At runtime all three levels of configuration are 




Supplementary Figure 7 
Butler compute cluster performance metrics during germline deletion genotyping for PCAWG 
 
 
(a) Overall load per VM that is part of the Butler cluster - shows no load prior to analysis kick-off, then steady load throughout the 
analysis, and drop-off in load at the end when VMs start running  out of work. (b) CPU profile shows highly variable CPU utilization that 
is typical of Delly executions. (c) Memory profile is stable and similar between all VMs that are running the analysis. Similar 
measurements have been observed over the other 5 analyses performed with Butler during PCAWG, although the exact pattern of CPU 




Supplementary Figure 8 
SQL Database state monitoring dashboard 
SQL Database health can be ascertained from logs harvested on the database server. (a) 75th, 99th, and 99.5th percentile of query 
response times. (b) Count queries by type. (c) Database READ and WRITE counts. (d) Data throughput in and out. These 
measurements were collected over a single 2-hour run of the software and serve as an example of visualization capabilities, not an 
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Yes Yes No No No 
Networking 
and security No Yes No No No 
Health 
Metrics No Yes No No No 
Log 
Harvesting No Yes No No No 
Anomaly 




No Yes No No No 
Self-healing No Yes No No No 
Docker 
support Yes Yes Yes Yes No 
CWL support Yes Yes Yes No No 
Code sharing 
integration Yes Yes No Yes No 
Workflow 
modules No Yes No Yes No 
DAG 






No Yes Yes Yes No 
Supplementary Table 1 - Comparison of cloud-enabled scientific workflow frameworks. * full support is 
defined here to mean that all or most features of the framework are available on that cloud, including 
automated configuration, networking, security, storage, metrics, monitoring, and anomaly detection. ** 
partial support is defined to mean that only a partial implementation exists for a cloud, with fewer 




















































SNV Discovery 0.27 
SNV Genotyping 0.90 
SV Duplications 0.39 
SV Deletions 0.28 
Supplementary Table 3 - Optimal rates for PCAWG and Butler pipelines. 
  
Supplementary Note 1 
Below is a detailed description of the various sub-systems of Butler. 
Cluster Lifecycle Management 
This sub-system deals with the task of creating and tearing down clusters on various 
clouds, including defining VMs, storage devices, network topology, and network security 
rules. To fulfill these requirements in a cloud agnostic manner Butler utilizes an open-
source framework called Terraform, developed by Hashicorp. Terraform uses a 
proprietary human- and machine-readable file format for specifying cluster 
configurations that is called HashiCorp Configuration Language (HCL). Using this 
language the end user can define a number of constructs for cluster management. The key 
task of Terraform is to perform Create, Read, Update, and Delete on cluster resources. 
Running Terraform causes the tool to inspect the current state and compare it to the target 
state, issuing any necessary commands to update current state to the target. Butler comes 
with a set of Terraform configuration files that define templates for all of the VMs that 
constitute a functional Butler cluster, as well as configurations for network security. A 
typical Butler cluster consists of Control VMs and Worker VMs and templates for both 
are available. The users are expected to adapt the templates as needed for their use case, 
providing their own credentials, cluster size, and other configurations. 
Cluster Configuration Management 
This sub-system deals with configuration and software installation of all VMs in the 
cluster. VMs typically will have hundreds of programs installed and configured on them, 
oftentimes with intricate interdependencies and inter-machine communication 
requirements. The Saltstack open-source Configuration Management system integrated in 
Butler allows managing these dependencies and installation details independently of the 
Operating System (OS) chosen for the Virtual Machines for deployments involving 
hundreds of servers (Figure 1). The Configuration Management System is controlled by 
a Master node that acts as the authority on the state of a cluster of Minion nodes. The 
Master has a set of configuration definitions defined and accessible through a git 
repository. Each Minion can have a number of roles assigned to it, and the Master 
maintains mappings between roles and configuration definitions. Once the Master has 
determined what roles a Minion has it can issue the necessary commands to apply 
relevant configurations to the Minion.  Butler ships with configuration definitions 
required to run Butler itself as well as those needed to execute the bundled workflows 
(for example, sequence alignment with BWA, germline variant calling with freebayes 
and Delly, and somatic variant calling with Sanger Institute’s CGP tools). Additional 
configurations can be defined by the user as necessary. 
Workflow System 
  
The Workflow sub-system is responsible for allowing users to define and run scientific 
workflows on the cloud. Butler integrates the open-source distributed workflow system 
called Airflow, originally developed by Airbnb (www.airbnb.com), for this purpose. The 
key component at the heart of Airflow is the Airflow Scheduler (Figure 1). The airflow-
scheduler is a service that runs perpetually on a VM and examines the state of all running 
workflows. All workflow tasks that meet the preconditions for being runnable are 
immediately "scheduled" for execution. In the context of Airflow scheduling means 
depositing the task into a queue (running on a separate Queue Server VM) from which a 
Worker VM (Figure 1) can eventually pick it up. The Worker VMs run an airflow-
worker service that periodically polls the task queue for available tasks, and when the 
task is runnable by a particular Worker, that Worker consumes the task message from the 
queue and assumes execution. In order to keep track of the status of Workers and 
workflow execution each Worker periodically sends heartbeat messages to the Scheduler 
to communicate its state. The state is persisted by the Scheduler to a PostgreSQL 
database, which runs on a DB Server VM (Figure 1).  
 
The user can communicate with and commandeer Airflow via the Airflow CLI, as well as 
a Web UI. The Web UI is provided via the airflow-flower, and airflow-webserver 
services, which can run on the same VM as the Scheduler or on a separate VM, 
depending on system load. Conceptually, an Airflow workflow is a Directed Acyclic 
Graph whose vertices represent tasks and edges indicate task sequence. In its 
implementation, an Airflow workflow is a Python program that can use any Python 
language construct or library. This allows the users to create workflows of arbitrary 
complexity and functionality. 
 
An Analysis Tracker module is built into Butler in order to allow the user to define 
analyses, specify what workflows are part of these analyses, and track the status and 
execution of Analysis Runs - instances of running a particular workflow on a particular 
data sample within the context of an Analysis (Supplementary Figure 4). 
 
When an Analysis Run is first created it is given a Ready status (Supplementary Figure 
5), indicating that it is ready to be scheduled for execution. Once the Scheduler has 
scheduled the Run for execution it is given a Scheduled status. When workflow execution 
starts the Run is marked In-Progress. Once the Run is successfully completed it enters a 
Completed status. If, at any point, the Run encounters an error condition it cannot recover 
from, the Run Status is set to Error. When the error condition is addressed the Run status 
should be set to Ready so that it can start from the beginning. 
 
In order to fulfill the workflow configuration and parametrisation requirements Butler 
implements a tri-level configuration mechanism (Supplementary Figure 6), allowing the 
user to specify configurations at Workflow, Analysis, and Analysis Run levels. At 
runtime all three configuration levels are merged into one “effective” configuration that 
applies within the execution context. Because it is important for configurations to be both 
human-readable and machine-readable Butler uses the JSON format to encode 
configuration information. PostgreSQL, in turn, has native support for storage and deep 
querying of JSON values, thus making it an ideal choice for configuration persistence. 
 
 
Operational Management  
 
This sub-system provides tools for ensuring continuous successful operation of the 
cluster, as well as for troubleshooting error conditions. In general, the Operational 
Management tools fall into two categories, those that collect observations about the state 
of each component in the system at runtime, and those that aggregate this data and 
present it to the user in the form of queryable databases and management reports. We 
delineate two major sources of data that are indicative of system state - System Metrics, 
and Server Logs. While metrics provide more of a coarse-grained view of the overall 
health of a particular Virtual Machine, server logs can give much more of a fine-grained 
view of the underlying system at an application level, and down to individual lines of 
code that are running at any given time. Butler has dedicated components for the 
collection and management of these data sets 
 
Each VM runs a metric collection daemon called Telegraf, which is an open-source 
package that is able to make periodic measurements of a large number of system metrics 
and ship them off to a centralized Monitoring Server. The definition for which metrics 
are collected is specified in a special configuration file. Because we are interested in 
observing not only the metrics as they are measured in the present, but also the dynamics 
of how metric values change over time, we need a mechanism for persisting this 
information. For this purpose the Monitoring Server component of Butler contains an 
instance of a database product called InfluxDB, which is an Open Source database system 
that is optimized for recording time series data. 
 
The metrics collection system is collecting 50 different metrics per host on average, 
sampled at intervals of 10 seconds. Given a cluster of 200 Virtual Machines the 
monitoring system collects and stores 86,400,000 data points in a 24 hour time period. 
This volume of data is quite difficult for the user to comprehend and make use of, and 
Butler provides visualization tools to enable the display of aggregate statistics based on 
the monitoring data using a Graphical User Interface (Supplementary Figure 7). The 
main goal of the visualizations is to give the user an overview of the trends observed 
within the compute cluster with respect to a set of representative performance metrics, 
and to alert the user to any conditions that threaten the health of Virtual Machines and the 
scientific analyses they run. 
 
Because of the potentially extremely high value of the information contained in server 
logs, we deploy a system of log harvesting and centralized storage that enables the 
Virtual Machines that are part of Butler to parse the logs that are being generated locally 
for interesting events and send those events to a centralized search index which is 
amenable to efficient querying and visualization. These open-source tools are known as 
the ELK stack (Elasticsearch, Logstash, Kibana). 
 
Each Virtual Machine in the cluster runs a log shipper - Filebeat. It is responsible for 
finding, harvesting, and locally aggregating logs. Logstash runs on a separate centralized 
server and is responsible for parsing the logs forwarded from Filebeat and sending the 
parsed information on to the Elasticsearch index. Elasticsearch is a general-purpose 
scalable text indexing and search engine that supports clustering and sharing of data. Just 
as it is difficult to grasp and analyze performance metrics due to the number of data-
points generated, it is as difficult to grasp log messages from a large cluster. We utilize a 
similar set of visualization tools to the ones we use for metrics, to solve this problem for 
server logs within Butler. The Kibana dashboarding framework allows us to create 
graphical dashboards that visualize log events of interest, as well as providing a web-
based query interface to the Elasticsearch log messages index (Supplementary Figure 
8). 
 
The Monitoring Server runs an anomaly detection and alerting library called Kapacitor, 
which defines a series of rules that specify the normal operating conditions for the 
cluster, such as all hosts regularly responding to ping, CPU below 80%, disk utilization 
below 85%, workflow tasks and other Butler services sending heartbeats every minute. 
Coupled with the application metrics gatherer statsd, the system builds an empirical 
distribution of the duration of various workflow tasks and knows when tasks take longer 
than they historically have. The anomaly detection software monitors the time series 
database that records all metrics and periodically evaluates the rule-set against it. When 
the system detects a breach of one or more rules it can take a remedial action, such as 
sending a warning email, a message to a Slack topic, a Telegram, or schedule the restart 
of a particular service, workflow or the reprovisioning of a particular VM (Figure 1 b). 
These abilities allow Butler users to be always up to date about the health of the system 
and allow Butler clusters to self-heal when they encounter problematic scenarios.  
 
This approach is markedly different, and offers dramatic improvements, over error 
handling routines implemented in other workflow frameworks. Nextflow, for instance, 
provides a workflow onError event handler and an errorStrategy 
(https://www.nextflow.io/blog/2016/error-recovery-and-automatic-resources-
management.html); these allow for simple retry logic to be set up including the ability to 
request more resources (such as memory) during the retries, and possibly notify users via 
email – but to trigger this routine requires that a workflow can signal the error, which in 
practice will often not be the case. Toil, similarly, allows for job retries upon failure 
(http://toil.readthedocs.io/en/releases-3.6.x/running/running.html#error-
handling-and-resuming-pipelines), again requiring that workflows are able to report 
crashes. These routines, therefore, are predicated on the workflows actually failing and 
being able to report that. In practice, workflow failure may not happen right away, may 
not happen at all, or may not be successfully reported, for example when systemic IT 
infrastructure issues are the root cause of failure – which in practice leaves significant 
gaps and is the cause of some of the hardest to detect, and costly project issues. 
Additionally, before the underlying issue is resolved, no amount of retrying will cause the 
workflow to succeed, ensuring that the workflow retry logic on its own has limited utility 
in practice.  
 
For example, consider a scenario where the job scheduler component crashes or stops 
responding. This does not cause any jobs to fail because they are handled by the worker 
nodes. Instead, new workflows simply fail to get scheduled, causing the system to slowly 
run out of work and become idle. In a large deployment with hundreds of VMs this 
condition quickly becomes costly, yet may go undetected because no workflows are 
failing. Butler deals with these situations easily, since it collects heartbeats from all 
essential services. As soon as the heartbeat is missing for a pre-determined period of time 
an alert is raised. Butler’s self-healing agent will communicate with Butler’s 
Configuration Server using its HTTP API and will instruct the Configuration Server to 
restart the Workflow Scheduler (Figure 1 b). If it is not able to bring the scheduler back 
online automatically it will alert users via email and Slack notifications.  
 
It is important to understand that even though Butler provides the anomaly-detection and 
self-healing framework along with some preconfigured rules and actions, the types of 
rules and actions that it makes sense to deploy at a given time is highly dependent on the 
context of the analysis being performed and the IT infrastructure that the system is 
deployed on. Thus, users should expect to spend effort working within this framework to 
properly set up and tune the rules that will best serve their needs. For example, if users 
set up a rule of the form “Automatically reschedule workflow tasks that have taken above 
3 standard deviations of the mean runtime and have not yet completed” and train this rule 
on a workflow that analyses small bacterial genomes, but then decide to deploy it on an 
organism with a much larger genome, this rule may trigger unnecessarily given marked 
differences in expected and acceptable runtimes. While high levels of automation can be 
extremely powerful and save time and costs when used in the right context, they may also 
wreak havoc when ill-configured. 
 
There are in general three types of situations that the anomaly detection and self-healing 
components can go after: 
 
The most high-level scenario involves detecting and resolving when an entire VM 
becomes stuck or otherwise unresponsive. Detection is accomplished via an uptime 
metric, which is collected for all hosts and measures how long each host has been up. If 
this metric is not updated for a long time the VM can be considered “dead”. This is fairly 
easy to deal with when a VM is a worker node; a new node can simply be launched using 
Butler’s existing provisioning functionality. It is more difficult to replace one of the 
management nodes in an automated fashion due to the need to rescue and migrate 
existing services like databases and queues. Thus, it is recommended to run these services 
with standby backups if high availability is desired and manually replace the nodes that 
go out of commission. 
 
At times, one of the individual services that Butler relies upon for its operation will crash. 
The greatest majority of these can be solved by a service restart. Butler collects a 
heartbeat from all such services and when the heartbeat is not detected will attempt to 
restart the offending service via the Configuration Server (Figure 1 b). As Butler collects 
detailed statistics about each service it can potentially act on some other conditions that 
may affect a service (such as running out of disk space) in an automated fashion. There 
are scenarios, however, such as network outages, which are impossible to fix 
automatically; if Butler is not able to bring the service back online after several tries it 
will notify a human via email and Slack notifications to ensure the issue will be resolved 
through human intervention, in a timely manner. 
 
The most advanced and fine-grained application of anomaly-detection is instrumenting 
individual workflows with metrics using the statsd library in order to collect timings, 
CPU, memory, and disk footprint. This allows the finest degree of automated control over 
workflow execution letting the system operator to detect workflows that are not crashing, 
but are not likely to ever finish because of a bug in the software or a data issue. Setting 
appropriate detection thresholds for these types of events requires detailed understanding 
of the resource requirements and usage patterns of the underlying algorithms that are 
being implemented by the workflow. Usage of these features is highly recommended for 
large-scale, long-running projects (e.g. studies at the scale of PCAWG or PPCG) or for 
ongoing production operations with a high degree of tuning. 
 
Although the anomaly-detection and self-healing capabilities of Butler are extremely 
powerful, they also have some remaining limitations. Since these components themselves 
are not immune to failure, adverse events that impact their ability to function will 
inevitably prevent the system from being able to adequately detect and respond to other 
failures. This includes failures of individual metrics collection agents, the time-series 
database, the rules engine, and the configuration server, as well as system-wide events 
like network outages that prevent VMs from being able to communicate with each other. 
In this regard the time series database and the rules engine stand out as single points of 
failure for the entire self-healing functionality while the failure of other components will 
only have a limited effect. These key components, however, can be deployed in cluster 
mode with standby backups to mitigate the risk of such events. One additional source of 
issues that is difficult for the self-healing functionality to address is the class of errors 
caused by data issues. Such issues are virtually impossible to deal with generically, and 
require a degree of expert understanding of the underlying data sets and data formats that 
we would advise against implementing at this level of a workflow system. Instead, we 
would recommend implementing the data quality assurance steps as a separate workflow 
that should run over the samples before they undergo further analysis. 
 
The anomaly detection and self-healing capabilities of Butler implement a host-, service-, 
and workflow-level quality assurance framework that dramatically increases system 
robustness when operating at large scale. It should be used with care, however, to not 
over-automate, inadvertently introducing false-positive signals, in order for the users to 
reap the most benefit from this powerful functionality.  
 
The Butler framework consists of many different services that reside on a number of 
different servers and need to be able to communicate with each other. To accomplish this 
in a flexible manner we needed to establish a Service Registry so that IP addresses of 
servers that host particular services can be looked up by service name. To accomplish 
this, Butler uses an open-source service discovery framework called Consul. Consul 
provides a cross-data-center distributed Service Name Registry that is available via 
HTTP and DNS protocols. In addition to registry capabilities Consul provides basic 
health checks for the underlying services, testing whether the IP and port the service is 
supposed to be listening on are actually reachable. 
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Herrmann28,30,273, Julian M. Hess3,152, Asger Hobolth154,206, Ermin Hodzic156, Chen Hong127,128, Henrik 
Hornshøj153, Keren Isaev12,18, Jose M. G. Izarzugaza260, Rory Johnson263,274, Todd A. Johnson233, Malene Juul153, 
Randi Istrup Juul153, Andre Kahles112,113,114,115,175, Abdullah Kahraman250,251,252, Manolis Kellis3,253, Ekta 
Khurana70,71,72,73, Jaegil Kim3, Jong K. Kim275, Youngwook Kim164,165, Jan Komorowski268,276, Jan O. Korbel7,8, 
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Sushant Kumar63,64, Andrés Lanzós263,264,274, Erik Larsson112, Donghoon Lee64, Kjong-Van 
Lehmann112,114,115,174,175, Shantao Li64, Xiaotong Li64, Ziao Lin3,277, Eric Minwei Liu71,73,278, Lucas 
Lochovsky63,64,186, Shaoke Lou63,64, Tobias Madsen153, Kathleen Marchal279,280, Iñigo Martincorena1, Alexander 
Martinez-Fundichely71,72,73, Yosef E. Maruvka3,19,152, Patrick D. McGillivray63, William Meyerson64,281, Ferran 
Muiños87,89, Loris Mularoni87,89, Hidewaki Nakagawa81, Morten Muhlig Nielsen153, Marta Paczkowska12, 
Keunchil Park282,283, Kiejung Park284, Tirso Pons285, Sergio Pulido-Tamayo279,280, Jüri Reimand12,18, Iker Reyes-
Salazar87, Matthew A. Reyna286, Esther Rheinbay3,6,19, Mark A. Rubin274,287,288,289,290, Carlota Rubio-Perez87,89,203, 
S. Cenk Sahinalp147,155,156, Gordon Saksena3, Leonidas Salichos63,64, Chris Sander112,157,291,292, Steven E. 
Schumacher3,204, Mark Shackleton271, Ofer Shapira3,157, Ciyue Shen292,293, Raunak Shrestha147, Shimin Shuai12,13, 
Nikos Sidiropoulos100, Lina Sieverling127,128, Nasa Sinnott-Armstrong3,45, Lincoln D. Stein12,13, David 
Tamborero87,89, Grace Tiao3, Tatsuhiko Tsunoda233,294,295,296, Husen M. Umer268,297, Liis Uusküla-Reimand298,299, 
Alfonso Valencia40,76, Miguel Vazquez40,41, Lieven P. C. Verbeke280,300, Claes Wadelius301, Lina Wadi12, Jiayin 
Wang27,58,158, Jonathan Warrell63,64, Sebastian M. Waszak8, Joachim Weischenfeldt8,99,100, Guanming Wu302, Jun 
Yu303, Jing Zhang64, Xuanping Zhang158,304, Yan Zhang64,305,306, Zhongming Zhao307, Lihua Zou308, Christian von 
Mering252,254, Mark Gerstein63,64,69, Gad Getz3,4,5,6, Michael S. Lawrence3,19,233, Jakob Skou Pedersen153,154, 
Benjamin J. Raphael286, Joshua M. Stuart9 & David A. Wheeler33,34 
PCAWG Transcriptome Working Group Samirkumar B. Amin184,185,186, Philip Awadalla12,13, Peter J. 
Bailey187, Claudia Calabrese7,8, Aurélien Chateigner15, Isidro Cortés-Ciriano93,94,95, Brian Craft132, David 
Craft3,309, Chad J. Creighton200, Natalie R. Davidson112,114,115,117,174, Deniz Demircioğlu178,179, Serap Erkek8, 
Nuno A. Fonseca7,133, Milana Frenkel-Morgenstern188, Mary J. Goldman132, Liliana Greger7, Jonathan 
Göke178,201, Yao He176, Katherine A. Hoadley23,24, Yong Hou180,181, Matthew R. Huska118, Andre 
Kahles112,113,114,115,175, Ekta Khurana70,71,72,73, Helena Kilpinen189, Jan O. Korbel7,8, Fabien C. Lamaze12, Kjong-
Van Lehmann112,114,115,174,175, Chang Li180,181, Siliang Li180,181, Xiaobo Li180,181, Xinyue Li180, Dongbing Liu180,181, 
Fenglin Liu176,177, Xingmin Liu180,181, Maximillian G. Marin37, Julia Markowski118, Matthew Meyerson3,6,157, 
Tannistha Nandi190, Morten Muhlig Nielsen153, Akinyemi I. Ojesina191,192,193, B. F. Francis Ouellette16,17, Qiang 
Pan-Hammarström180,194, Peter J. Park94,95, Chandra Sekhar Pedamallu3,6,168, Jakob Skou Pedersen153,154, Marc D. 
Perry14,15, Roland F. Schwarz7,118,119,120, Yuichi Shiraishi39, Reiner Siebert79,80, Cameron M. Soulette37, Stefan G. 
Stark115,174,182,183, Oliver Stegle7,8,124, Hong Su180,181, Patrick Tan190,195,196,197, Bin Tean Teh195,196,197,198,199, Lara 
Urban7,8, Jian Wang180, Sebastian M. Waszak8, Kui Wu180,181, Qian Xiang134, Heng Xiong180,181, Sergei 
Yakneen8, Huanming Yang180, Chen Ye180,181, Christina K. Yung15, Fan Zhang176, Junjun Zhang15, Xiuqing 
Zhang180, Zemin Zhang176,202, Liangtao Zheng176, Jingchun Zhu132, Shida Zhu180,181, Alvis Brazma7, Angela N. 
Brooks3,37,157 & Gunnar Rätsch112,113,114,115,116,117 
PCAWG Epigenome Working Group Hiroyuki Aburatani310, Hans Binder311,312, Huy Q. Dinh313, Lars 
Feuerbach127, Shengjie Gao180, Ivo G. Gut49,74, Simon C. Heath49,74, Steve Hoffmann311,312,314,315, Charles David 
Imbusch127, Ekta Khurana70,71,72,73, Helene Kretzmer312,315, Peter W. Laird316, Jose I. Martin-Subero76,317, Genta 
Nagae310,318, Paz Polak3,4,6, Hui Shen319, Reiner Siebert79,80, Nasa Sinnott-Armstrong3,45, Miranda D. Stobbe49,74, 
Qi Wang246, Dieter Weichenhan320, Sergei Yakneen8, Wanding Zhou319, Benjamin P. Berman313,321,322, Benedikt 
Brors127,150,323 & Christoph Plass320 
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PCAWG Structural Variation Working Group Kadir C. Akdemir141, Eva G. Alvarez42,43,44, Adrian Baez-
Ortega55, Paul C. Boutros12,18,20,21, David D. L. Bowtell271, Benedikt Brors127,150,323, Kathleen H. Burns324,325, 
John Busanovich3,326, Kin Chan327, Ken Chen141, Isidro Cortés-Ciriano93,94,95, Ana Dueso-Barroso40, Andrew J. 
Dunford3, Paul A. Edwards328,329, Xavier Estivill47,84, Dariush Etemadmoghadam271, Lars Feuerbach127, J. Lynn 
Fink40,269, Milana Frenkel-Morgenstern188, Dale W. Garsed271, Mark Gerstein63,64,69, Dmitry A. Gordenin97, 
David Haan9, James E. Haber330, Julian M. Hess3,152, Barbara Hutter140,149,150, Marcin Imielinski166,167, David T. 
W. Jones331,332, Young Seok Ju1,267, Marat D. Kazanov333,334,335, Leszek J. Klimczak98, Youngil Koh336,337, Jan O. 
Korbel7,8, Kiran Kumar3, Eunjung Alice Lee338, Jake June-Koo Lee94,95, Yilong Li1, Andy G. Lynch328,329,339, 
Geoff Macintyre328, Florian Markowetz328,329, Iñigo Martincorena1, Alexander Martinez-Fundichely71,72,73, 
Matthew Meyerson3,6,157, Satoru Miyano39, Hidewaki Nakagawa81, Fabio C. P. Navarro63, Stephan 
Ossowski47,48,49, Peter J. Park94,95, John V. Pearson340,341, Montserrat Puiggròs40, Karsten Rippe120, Nicola D. 
Roberts1, Steven A. Roberts107, Bernardo Rodriguez-Martin42,43,44, Steven E. Schumacher3,204, Ralph Scully342, 
Mark Shackleton271, Nikos Sidiropoulos100, Lina Sieverling127,128, Chip Stewart3, David Torrents40,76, Jose M. C. 
Tubio42,43,44, Izar Villasante40, Nicola Waddell340,341, Jeremiah A. Wala3,6,157, Joachim Weischenfeldt8,99,100, 
Lixing Yang343, Xiaotong Yao166,344, Sung-Soo Yoon337, Jorge Zamora1,42,43,44, Cheng-Zhong Zhang3,6,157, 
Rameen Beroukhim3,6,168 & Peter J. Campbell1,2 
PCAWG Mutational Signatures Working Group Ludmil B. Alexandrov1,101, Erik N. Bergstrom345, Arnoud 
Boot196,346, Paul C. Boutros12,18,20,21, Kin Chan327, Kyle Covington34, Akihiro Fujimoto81, Gad Getz3,4,5,6, Dmitry 
A. Gordenin97, Nicholas J. Haradhvala3,19, Mi Ni Huang196,346, S. M. Ashiqul Islam101, Marat D. 
Kazanov333,334,335, Jaegil Kim3, Leszek J. Klimczak98, Michael S. Lawrence3,19,233, Iñigo Martincorena1, John R. 
McPherson196,346, Sandro Morganella1, Ville Mustonen347,348,349, Hidewaki Nakagawa81, Alvin Wei Tian Ng350, 
Paz Polak3,4,6, Stephenie D. Prokopec12, Steven A. Roberts107, Radhakrishnan Sabarinathan87,88,89, Natalie 
Saini97, Tatsuhiro Shibata226,227, Yuichi Shiraishi39, Ignacio Vázquez-García1,67,354,355, Yang Wu196,346, Fouad 
Yousif12, Willie Yu356, Steven G. Rozen196,197,346, Michael R. Stratton1 & Bin Tean Teh195,196,197,198,199 
PCAWG Germline Cancer Genome Working Group Ludmil B. Alexandrov1,101, Eva G. Alvarez42,43,44, 
Adrian Baez-Ortega55, Matthew H. Bailey26,27, Mattia Bosio40,47,49, G. Steven Bova126, Alvis Brazma7, Alicia L. 
Bruzos42,43,44, Ivo Buchhalter28,29,30, Carlos D. Bustamante45,78, Atul J. Butte121, Andy Cafferkey7, Claudia 
Calabrese7,8, Peter J. Campbell1,2, Stephen J. Chanock96, Nilanjan Chatterjee122,123, Jieming Chen64,110, Francisco 
M. De La Vega45,46,78, Olivier Delaneau50,51,52, German M. Demidov47,48,49, Anthony DiBiase60, Li Ding26,27,35, 
Oliver Drechsel47,49, Lewis Jonathan Dursi12,25, Douglas F. Easton82,83, Serap Erkek8, Georgia Escaramis47,103,104, 
Erik Garrison1, Mark Gerstein63,64,69, Gad Getz3,4,5,6, Dmitry A. Gordenin97, Nina Habermann8, Olivier 
Harismendy125, Eoghan Harrington105, Shuto Hayashi39, Seong Gu Heo173, José María Heredia-Genestar54, 
Aliaksei Z. Holik47, Eun Pyo Hong173, Xing Hua96, Kuan-lin Huang27,61, Seiya Imoto39, Sissel Juul105, Ekta 
Khurana70,71,72,73, Hyung-Lae Kim56, Youngwook Kim164,165, Leszek J. Klimczak98, Roelof Koster108, Sushant 
Kumar63,64, Ivica Letunic62, Yilong Li1, Tomas Marques-Bonet74,75,76,77, R. Jay Mashl27,57, Simon Mayes106, 
Michael D. McLellan26,27,35, Lisa Mirabello96, Francesc Muyas47,48,49, Hidewaki Nakagawa81, Arcadi 
Navarro74,75,76, Steven J. Newhouse7, Stephan Ossowski47,48,49, Ji Wan Park173, Esa Pitkänen8, Aparna Prasad49, 
Raquel Rabionet47,49,102, Benjamin Raeder8, Tobias Rausch8, Steven A. Roberts107, Bernardo Rodriguez-
Martin42,43,44, Vasilisa A. Rudneva8, Gunnar Rätsch112,113,114,115,116,117, Natalie Saini97, Matthias Schlesner28,31, 
Roland F. Schwarz7,118,119,120, Ayellet V. Segre3,53, Tal Shmaya46, Suyash S. Shringarpure45, Nikos 
Page 9 of 46 
 
Sidiropoulos100, Reiner Siebert79,80, Jared T. Simpson12,36, Lei Song96, Oliver Stegle7,8,124, Hana Susak47,49, 
Tomas J. Tanskanen109, Grace Tiao3, Marta Tojo44, Jose M. C. Tubio42,43,44, Daniel J. Turner106, Lara Urban7,8, 
Sebastian M. Waszak8, David C. Wedge1,65,66, Joachim Weischenfeldt8,99,100, David A. Wheeler33,34, Mark H. 
Wright45, Dai-Ying Wu46, Tian Xia357, Sergei Yakneen8, Kai Ye58,59, Venkata D. Yellapantula67,68, Jorge 
Zamora1,42,43,44, Bin Zhu96, Xavier Estivill47,84 & Jan O. Korbel7,8 
PCAWG Pathology and Clinical Correlates Working Group Fatima Al-Shahrour135, Gurnit Atwal12,13,172, 
Peter J. Bailey187, Paul C. Boutros12,18,20,21, Peter J. Campbell1,2, David K. Chang187,358, Susanna L. Cooke187, 
Vikram Deshpande19, Bishoy M. Faltas117, William C. Faquin19, Gad Getz3,4,5,6, Syed Haider12, Wei Jiao12, Vera 
B. Kaiser359, Rosa Karlić360, Mamoru Kato361, Kirsten Kübler3,6,19, Alexander J. Lazar22, Constance H. Li12,18, 
David N. Louis19, Adam Margolin38, Sancha Martin1,362, Hardeep K. Nahal-Bose15, G. Petur Nielsen19, Serena 
Nik-Zainal1,351,352,353, Larsson Omberg85, Christine P’ng12, Marc D. Perry14,15, Paz Polak3,4,6, Esther 
Rheinbay3,6,19, Mark A. Rubin274,287,288,289,290, Colin A. Semple359, Dennis C. Sgroi19, Tatsuhiro Shibata226,227, 
Reiner Siebert79,80, Jaclyn Smith38, Miranda D. Stobbe49,74, Ren X. Sun12, Kevin Thai15, Derek W. Wright363,364, 
Chin-Lee Wu19, Ke Yuan328,362,365, Junjun Zhang15, Andrew V. Biankin187,358,366,367, Levi Garraway157, Sean M. 
Grimmond368, Katherine A. Hoadley23,24 & Lincoln D. Stein12,13 
PCAWG Evolution & Heterogeneity Working Group David J. Adams1, Pavana Anur369, Rameen 
Beroukhim3,6,168, Paul C. Boutros12,18,20,21, David D. L. Bowtell271, Peter J. Campbell1,2, Shaolong Cao32, 
Elizabeth L. Christie271, Marek Cmero370,371,372, Yupeng Cun373, Kevin J. Dawson1, Jonas Demeulemeester91,92, 
Stefan C. Dentro1,65,91, Amit G. Deshwar374, Nilgun Donmez147,156, Ruben M. Drews328, Roland Eils28,30,143,144, 
Yu Fan32, Matthew W. Fittall91, Dale W. Garsed271, Moritz Gerstung7,8, Gad Getz3,4,5,6, Santiago Gonzalez7,8, 
Gavin Ha3, Kerstin Haase91, Marcin Imielinski166,167, Lara Jerman8,375, Yuan Ji376,377, Clemency Jolly91, Kortine 
Kleinheinz28,30, Juhee Lee378, Henry Lee-Six1, Ignaty Leshchiner3, Dimitri Livitz3, Geoff Macintyre328, Salem 
Malikic147,156, Florian Markowetz328,329, Iñigo Martincorena1, Thomas J. Mitchell1,329,379, Quaid D. Morris172,380, 
Ville Mustonen347,348,349, Layla Oesper381, Martin Peifer373, Myron Peto382, Benjamin J. Raphael286, Daniel 
Rosebrock3, Yulia Rubanova36,172, S. Cenk Sahinalp147,155,156, Adriana Salcedo12, Matthias Schlesner28,31, Steven 
E. Schumacher3,204, Subhajit Sengupta383, Ruian Shi380, Seung Jun Shin183, Oliver Spiro3, Lincoln D. Stein12,13, 
Maxime Tarabichi1,91, Shankar Vembu380,384, Ignacio Vázquez-García1,67,354,355, Wenyi Wang32, David A. 
Wheeler33,34, Jeffrey A. Wintersinger170,171,172, Tsun-Po Yang373, Xiaotong Yao166,344, Kaixian Yu385, Ke 
Yuan328,362,365, Hongtu Zhu386,387, Paul T. Spellman388, Peter Van Loo91,92 & David C. Wedge1,65,66 
PCAWG Portals and Visualization Working Group Fatima Al-Shahrour135, Elisabet Barrera7, Wojciech 
Bazant7, Alvis Brazma7, Isidro Cortés-Ciriano93,94,95, Brian Craft132, David Craft3,309, Vincent Ferretti15,86, Nuno 
A. Fonseca7,133, Anja Füllgrabe7, Mary J. Goldman132, Wolfgang Huber8, Maria Keays7, Alfonso Muñoz7, Brian 
D. O’Connor15,37, Irene Papatheodorou7, Robert Petryszak7, Elena Piñeiro-Yáñez135, Alfonso Valencia40,76, John 
N. Weinstein137,138, Qian Xiang134, Junjun Zhang15, David Haussler132,136, Miguel Vazquez40,41 & Jingchun 
Zhu132 
PCAWG Mitochondrial Genome and Immunogenomics Working Group Peter J. Campbell1,2, Yiwen 
Chen32, Chad J. Creighton200, Li Ding26,27,35, Akihiro Fujimoto81, Masashi Fujita81, Gad Getz3,4,5,6, Leng Han304, 
Takanori Hasegawa39, Shuto Hayashi39, Seiya Imoto39, Young Seok Ju1,267, Hyung-Lae Kim56, Youngwook 
Kim164,165, Youngil Koh336,337, Mitsuhiro Komura39, Jun Li32, Iñigo Martincorena1, Satoru Miyano39, Shinichi 
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Mizuno389, Keunchil Park282,283, Eigo Shimizu39, Yumeng Wang32,390, John N. Weinstein137,138, Yanxun Xu391, 
Rui Yamaguchi39, Fan Yang380, Yang Yang304, Christopher J. Yoon267, Sung-Soo Yoon337, Yuan Yuan32, Fan 
Zhang176, Zemin Zhang176,202, Han Liang32 & Hidewaki Nakagawa81 
PCAWG Pathogens Working Group Malik Alawi392,393, Ivan Borozan12, Daniel S. Brewer394,395, Colin S. 
Cooper395,396,397, Nikita Desai15, Roland Eils28,30,143,144, Vincent Ferretti15,86, Adam Grundhoff392,398, Murat 
Iskar399, Kortine Kleinheinz28,30, Hidewaki Nakagawa81, Akinyemi I. Ojesina191,192,193, Chandra Sekhar 
Pedamallu3,6,168, Matthias Schlesner28,31, Xiaoping Su400, Marc Zapatka399 & Peter Lichter149,399 
Providers of tumour-sequencing data 
Tumour-specific providers (ovarian cancer) in Australia Kathryn Alsop271, Timothy J. C. Bruxner269, 
Angelika N. Christ269, Elizabeth L. Christie271, Stephen M. Cordner403, Prue A. Cowin401, Ronny Drapkin404, 
Dariush Etemadmoghadam271, Sian Fereday401, Dale W. Garsed271, Joshy George186, Sean M. Grimmond368, 
Anne Hamilton401, Oliver Holmes340,341, Jillian A. Hung405,406, Karin S. Kassahn269,407, Stephen H. 
Kazakoff340,341, Catherine J. Kennedy408,409, Conrad R. Leonard340,341, Linda Mileshkin271, David K. 
Miller269,358,410, Gisela Mir Arnau401, Chris Mitchell401, Felicity Newell340,341, Katia Nones340,341, Ann-Marie 
Patch340,341, John V. Pearson340,341, Michael C. Quinn340,341, Mark Shackleton271, Darrin F. Taylor269, Heather 
Thorne401, Nadia Traficante401, Ravikiran Vedururu401, Nick M. Waddell341, Nicola Waddell340,341, Paul M. 
Waring411, Scott Wood340,341, Qinying Xu340,341, Anna deFazio412,413,414 & David D. L. Bowtell271 
Tumour-specific providers (pancreatic cancer) in Australia Matthew J. Anderson269, Davide Antonello415, 
Andrew P. Barbour416,417, Claudio Bassi415, Samantha Bersani418, Timothy J. C. Bruxner269, Ivana Cataldo418,419, 
David K. Chang187,358, Lorraine A. Chantrill358,420, Yoke-Eng Chiew412, Angela Chou358,421, Angelika N. 
Christ269, Sara Cingarlini229, Nicole Cloonan422, Vincenzo Corbo419,423, Maria Vittoria Davi424, Fraser R. 
Duthie187,425, J. Lynn Fink40,269, Anthony J. Gill358,421, Janet S. Graham187,426, Ivon Harliwong269, Oliver 
Holmes340,341, Nigel B. Jamieson187,367,427, Amber L. Johns358,410, Karin S. Kassahn269,407, Stephen H. 
Kazakoff340,341, James G. Kench358,421,428, Luca Landoni415, Rita T. Lawlor419, Conrad R. Leonard340,341, Andrea 
Mafficini419, Neil D. Merrett415,429, David K. Miller269,358,410, Marco Miotto415, Elizabeth A. Musgrove187, Adnan 
M. Nagrial358, Felicity Newell340,341, Katia Nones340,341, Karin A. Oien411,430, Marina Pajic358, Ann-Marie 
Patch340,341, John V. Pearson340,341, Mark Pinese431, Michael C. Quinn340,341, Alan J. Robertson269, Ilse 
Rooman358, Borislav C. Rusev419, Jaswinder S. Samra415,421, Maria Scardoni418, Christopher J. Scarlett358,432, 
Aldo Scarpa419, Elisabetta Sereni415, Katarzyna O. Sikora419, Michele Simbolo423, Morgan L. Taschuk15, 
Christopher W. Toon358, Giampaolo Tortora229,230, Caterina Vicentini419, Nick M. Waddell341, Nicola 
Waddell340,341, Scott Wood340,341, Jianmin Wu358, Qinying Xu340,341, Nikolajs Zeps433,434, Andrew V. 
Biankin187,358,366,367 & Sean M. Grimmond368 
Tumour-specific providers (skin cancer) in Australia Lauri A. Aaltonen111, Andreas Behren435, Hazel 
Burke436, Jonathan Cebon435, Rebecca A. Dagg437, Ricardo De Paoli-Iseppi438, Ken Dutton-Regester340, Matthew 
A. Field439, Anna Fitzgerald440, Sean M. Grimmond368, Peter Hersey436, Oliver Holmes340,341, Valerie Jakrot436, 
Peter A. Johansson340, Hojabr Kakavand438, Stephen H. Kazakoff340,341, Richard F. Kefford441, Loretta M. S. 
Lau442, Conrad R. Leonard340,341, Georgina V. Long443, Felicity Newell340,341, Katia Nones340,341, Ann-Marie 
Patch340,341, John V. Pearson340,341, Hilda A. Pickett442, Antonia L. Pritchard340, Gulietta M. Pupo444, Robyn P. 
M. Saw443, Sarah-Jane Schramm445, Mark Shackleton271, Catherine A. Shang440, Ping Shang443, Andrew J. 
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Spillane443, Jonathan R. Stretch443, Varsha Tembe412,445, John F. Thompson443, Ricardo E. Vilain446, Nick M. 
Waddell341, Nicola Waddell340,341, James S. Wilmott443, Scott Wood340,341, Qinying Xu340,341, Jean Y. Yang447, 
Nicholas K. Hayward340,436, Graham J. Mann412,448,449 & Richard A. Scolyer413,443,446,450 
Tumour-specific providers (pancreatic cancer) in Canada John Bartlett451,452, Prashant Bavi453, Ivan 
Borozan12, Dianne E. Chadwick454, Michelle Chan-Seng-Yue453, Sean Cleary453,455, Ashton A. Connor455,456, 
Karolina Czajka241, Robert E. Denroche453, Neesha C. Dhani457, Jenna Eagles241, Vincent Ferretti15,86, Steven 
Gallinger453,455,456, Robert C. Grant453,456, David Hedley457, Michael A. Hollingsworth458, Gun Ho Jang453, 
Jeremy Johns241, Sangeetha Kalimuthu453, Sheng-Ben Liang459, Ilinca Lungu453,460, Xuemei Luo12, Faridah 
Mbabaali241, Treasa A. McPherson456, Jessica K. Miller241, Malcolm J. Moore457, Faiyaz Notta453,461, Danielle 
Pasternack241, Gloria M. Petersen462, Michael H. A. Roehrl18,453,463,464,465, Michelle Sam241, Iris Selander456, 
Stefano Serra411, Sagedeh Shahabi459, Morgan L. Taschuk15, Sarah P. Thayer458, Lee E. Timms241, Gavin W. 
Wilson12,453, Julie M. Wilson453, Bradly G. Wouters466, Thomas J. Hudson240,241, John D. McPherson241,453,467 & 
Lincoln D. Stein12,13 
Tumour-specific providers (prostate cancer) in Canada Timothy A. Beck15,468, Vinayak Bhandari12, Colin C. 
Collins147, Shadrielle M. G. Espiritu12, Neil E. Fleshner469, Natalie S. Fox12, Michael Fraser12, Syed Haider12, 
Lawrence E. Heisler470, Vincent Huang12, Emilie Lalonde12, Julie Livingstone12, John D. McPherson241,453,467, 
Alice Meng471, Veronica Y. Sabelnykova12, Adriana Salcedo12, Yu-Jia Shiah12, Theodorus Van der Kwast472, 
Takafumi N. Yamaguchi12, Paul C. Boutros12,18,20,21 & Robert G. Bristow18,473,474,475,476 
Tumour-specific providers (gastric cancer) in China Shuai Ding477, Daiming Fan478, Yong Hou180,181, Yi 
Huang158,257, Lin Li180, Siliang Li180,181, Dongbing Liu180,181, Xingmin Liu180,181, Yongzhan Nie478,479, Hong 
Su180,181, Jian Wang180, Kui Wu180,181, Xiao Xiao158, Rui Xing222,480, Shanlin Yang477, Yingyan Yu481, Xiuqing 
Zhang180, Yong Zhou180, Shida Zhu180,181, Youyong Lu221,222,223 & Huanming Yang180 
Tumour-specific providers (renal cancer) in the EU and France Rosamonde E. Banks482, Guillaume 
Bourque483,484, Alvis Brazma7, Paul Brennan485, Louis Letourneau486, Yasser Riazalhosseini484, Ghislaine 
Scelo485, Naveen Vasudev482,487, Juris Viksna488, Mark Lathrop484 & Jörg Tost489 
Tumour-specific providers (breast cancer) in the EU & United Kingdom Sung-Min Ahn490, Ludmil B. 
Alexandrov1,101, Samuel Aparicio491, Laurent Arnould492, M. R. Aure493, Shriram G. Bhosle1, Ewan Birney7, 
Ake Borg494, Sandrine Boyault495, Arie B. Brinkman496, Jane E. Brock497, Annegien Broeks498, Adam P. Butler1, 
Anne-Lise Børresen-Dale493, Carlos Caldas499,500, Peter J. Campbell1,2, Suet-Feung Chin499,500, Helen 
Davies1,351,352, Christine Desmedt501,502, Luc Dirix503, Serge Dronov1, Anna Ehinger504, Jorunn E. Eyfjord505, 
Aquila Fatima204, John A. Foekens506, P. Andrew Futreal507, Øystein Garred508,509, Moritz Gerstung7,8, Dilip D. 
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